National Drug Strategy
National Drug Strategy

Comorbidity of mental disorders and substance use: a brief guide for the primary care clinician

6.8 Major clinical issues with anxiety disorders and inhalent/ solvent use

prev pageTOC |next page

Table of contents

6.8.1 Effects of inhalants/ solvents on anxiety disorders

6.8.2 Interactions between inhalants/ solvents and therapeutic agents for anxiety disorders

6.8.3 Management approaches to comorbid anxiety disorders and inhalant/ solvent use

Offer alternatives to inhalant use, for example, recreational activities.

prev pageTOC |next page